Nexus Investment Management Trimmed By $5.30 Million Its Apple (AAPL) Stake; 26 Analysts Bullish Boston Scientific (BSX)

Apple Inc. (NASDAQ:AAPL) Logo

Nexus Investment Management Inc decreased Apple Inc (AAPL) stake by 16.51% reported in 2018Q1 SEC filing. Nexus Investment Management Inc sold 31,755 shares as Apple Inc (AAPL)’s stock rose 5.37%. The Nexus Investment Management Inc holds 160,541 shares with $26.94 million value, down from 192,296 last quarter. Apple Inc now has $923.56 billion valuation. The stock decreased 0.36% or $0.68 during the last trading session, reaching $187.9. About 19.51 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 22.56% since May 30, 2017 and is uptrending. It has outperformed by 9.99% the S&P500.

Among 32 analysts covering Boston Scientific Corporation (NYSE:BSX), 26 have Buy rating, 0 Sell and 6 Hold. Therefore 81% are positive. Boston Scientific Corporation has $36 highest and $19 lowest target. $30.26’s average target is 0.20% above currents $30.2 stock price. Boston Scientific Corporation had 99 analyst reports since July 27, 2015 according to SRatingsIntel. On Thursday, February 25 the stock rating was initiated by SunTrust with “Buy”. The firm earned “Buy” rating on Tuesday, May 1 by Citigroup. Needham maintained the stock with “Buy” rating in Thursday, June 22 report. The rating was maintained by BMO Capital Markets with “Buy” on Monday, June 19. Citigroup initiated the shares of BSX in report on Thursday, November 12 with “Buy” rating. The company was maintained on Monday, May 1 by Oppenheimer. BMO Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Wednesday, October 11. BMO Capital Markets has “Buy” rating and $30.0 target. The firm has “Buy” rating by Citigroup given on Thursday, October 6. On Tuesday, September 22 the stock rating was initiated by UBS with “Buy”. RBC Capital Markets maintained the shares of BSX in report on Tuesday, May 30 with “Buy” rating. See Boston Scientific Corporation (NYSE:BSX) latest ratings:

01/05/2018 Broker: Citigroup Old Rating: Buy New Rating: Buy Old Target: $32 New Target: $34 Maintain
25/04/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $33.0000 Maintain
25/04/2018 Broker: Jefferies Rating: Hold New Target: $31.0000 Maintain
26/04/2018 Broker: Raymond James Old Rating: Strong Buy New Rating: Strong Buy Old Target: $32 New Target: $34 Maintain
26/04/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $32 New Target: $33 Maintain
26/04/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $31 New Target: $32 Maintain
25/04/2018 Broker: Needham Rating: Buy New Target: $36.0000 Maintain
05/04/2018 Broker: Bank of America Old Rating: Buy New Rating: Buy Old Target: $30 New Target: $34 Maintain
19/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $30 New Target: $33 Maintain
23/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $31.0 Initiate

The stock decreased 0.36% or $0.11 during the last trading session, reaching $30.2. About 3.88M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 11.19% since May 30, 2017 and is uptrending. It has underperformed by 1.38% the S&P500.

Another recent and important Boston Scientific Corporation (NYSE:BSX) news was published by Streetinsider.com which published an article titled: “JANA Shows New Stakes in Apple (AAPL), Boston Scientific (BSX), Dropbox (DBX), iQIYI (IQ) (more..) -13F” on May 15, 2018.

Investors sentiment decreased to 0.96 in Q1 2018. Its down 0.38, from 1.34 in 2017Q4. It dropped, as 42 investors sold Boston Scientific Corporation shares while 181 reduced holdings. 60 funds opened positions while 153 raised stakes. 1.18 billion shares or 0.46% less from 1.18 billion shares in 2017Q4 were reported. 1.09M are owned by Renaissance Technologies Limited Company. Nottingham Incorporated reported 31,786 shares. 277,500 were reported by Price Michael F. Panagora Asset Mngmt reported 67,762 shares. Aureus Asset Ltd stated it has 2.5% in Boston Scientific Corporation (NYSE:BSX). The Georgia-based Earnest Ltd Llc has invested 0% in Boston Scientific Corporation (NYSE:BSX). First Quadrant L P Ca holds 45,296 shares. Shelton Capital Management stated it has 11,526 shares. Van Cleef Asset Managementinc holds 0.06% in Boston Scientific Corporation (NYSE:BSX) or 8,900 shares. Da Davidson And reported 0.01% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Banced reported 0.9% in Boston Scientific Corporation (NYSE:BSX). Moreover, State Board Of Administration Of Florida Retirement Systems has 0.15% invested in Boston Scientific Corporation (NYSE:BSX). Suntrust Banks Inc has 434,113 shares for 0.08% of their portfolio. Adage Cap Prns Gru Ltd Liability Company has 0.15% invested in Boston Scientific Corporation (NYSE:BSX). 6,651 are held by Nuwave Invest Mgmt Ltd.

Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. The company has market cap of $41.66 billion. It operates through three divisions: Cardiovascular, Rhythm Management, and MedSurg. It has a 397.37 P/E ratio. The firm offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.

Since December 29, 2017, it had 0 insider purchases, and 18 insider sales for $9.29 million activity. Sorenson John Bradley sold 14,150 shares worth $381,949. Ballinger Kevin J. had sold 31,056 shares worth $931,680 on Monday, May 7. 5,152 shares valued at $141,319 were sold by Pierce David A on Thursday, February 1. $225,413 worth of stock was sold by Butcher Arthur C on Thursday, May 10. The insider Phalen Michael P. sold 15,835 shares worth $399,865. 60,209 shares were sold by Brennan Daniel J., worth $1.68M. Fitzgerald Joseph Michael sold 85,227 shares worth $2.26 million.

Since December 7, 2017, it had 0 buys, and 10 selling transactions for $47.05 million activity. On Thursday, April 12 Maestri Luca sold $6.83M worth of Apple Inc. (NASDAQ:AAPL) or 39,122 shares. $2.73M worth of Apple Inc. (NASDAQ:AAPL) shares were sold by Riccio Daniel J.. The insider KONDO CHRIS sold 4,867 shares worth $910,129. On Tuesday, April 3 SCHILLER PHILIP W sold $11.56M worth of Apple Inc. (NASDAQ:AAPL) or 69,491 shares. On Thursday, May 3 AHRENDTS ANGELA J sold $6.75M worth of Apple Inc. (NASDAQ:AAPL) or 38,228 shares. Shares for $2.90 million were sold by WILLIAMS JEFFREY E. The insider LEVINSON ARTHUR D sold 35,000 shares worth $6.51M.

Investors sentiment decreased to 0.69 in Q1 2018. Its down 0.04, from 0.73 in 2017Q4. It fall, as 69 investors sold AAPL shares while 1039 reduced holdings. 125 funds opened positions while 645 raised stakes. 2.86 billion shares or 3.74% less from 2.98 billion shares in 2017Q4 were reported. Knightsbridge Asset Ltd reported 46,893 shares. Provise Grp Ltd Liability Company stated it has 43,120 shares. Snow Mgmt Ltd Partnership holds 0.07% of its portfolio in Apple Inc. (NASDAQ:AAPL) for 9,377 shares. Oberweis Asset accumulated 0.13% or 2,878 shares. Longer Inc has 14,978 shares for 2.75% of their portfolio. Sanders Capital Limited Co owns 7.86% invested in Apple Inc. (NASDAQ:AAPL) for 8.47 million shares. Heritage Invsts Management has 307,089 shares. Diamond Hill Cap Mgmt accumulated 2.29M shares. Ironwood Financial Limited Liability Company invested in 0.48% or 2,639 shares. Huntington State Bank holds 1.85% or 663,038 shares. Menlo Advsr Ltd Company has invested 3% in Apple Inc. (NASDAQ:AAPL). Hutchinson Capital Mngmt Ca has invested 0.18% of its portfolio in Apple Inc. (NASDAQ:AAPL). Ferguson Wellman Inc holds 370,296 shares. Garnet Equity Holding has 4.14% invested in Apple Inc. (NASDAQ:AAPL). Lazard Asset Mgmt Ltd Liability Company has invested 1.47% in Apple Inc. (NASDAQ:AAPL).

Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 37 have Buy rating, 1 Sell and 18 Hold. Therefore 66% are positive. Apple Inc. has $235 highest and $11 lowest target. $175.76’s average target is -6.46% below currents $187.9 stock price. Apple Inc. had 417 analyst reports since July 21, 2015 according to SRatingsIntel. BMO Capital Markets maintained it with “Buy” rating and $180.0 target in Wednesday, September 13 report. The firm earned “Buy” rating on Monday, October 23 by UBS. The firm has “Buy” rating given on Friday, November 3 by Nomura. Mizuho maintained Apple Inc. (NASDAQ:AAPL) rating on Friday, September 11. Mizuho has “Neutral” rating and $125 target. The stock has “Outperform” rating by Cowen & Co on Friday, October 21. The rating was maintained by Loop Capital with “Buy” on Wednesday, January 31. The stock has “Buy” rating by Goldman Sachs on Wednesday, October 12. Cowen & Co maintained Apple Inc. (NASDAQ:AAPL) on Friday, July 7 with “Buy” rating. The firm has “Buy” rating given on Monday, June 12 by Macquarie Research. Wells Fargo downgraded Apple Inc. (NASDAQ:AAPL) on Thursday, September 8 to “Market Perform” rating.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Nasdaq.com which released: “Apple Inc. (AAPL) Likely to Adopt OLED Technology in 2019 iPhone Models” on May 29, 2018, also Seekingalpha.com with their article: “Apple Is Easy For Shareholders” published on May 29, 2018, 247Wallst.com published: “Google Tops Apple as World’s Most Valuable Brand” on May 29, 2018. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Livetradingnews.com and their article: “Apple Inc. (NASDAQ:AAPL) Stock Consolidating” published on May 29, 2018 as well as Seekingalpha.com‘s news article titled: “iPhone display makers sink on OLED report” with publication date: May 29, 2018.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on August, 7. They expect $2.19 earnings per share, up 31.14% or $0.52 from last year’s $1.67 per share. AAPL’s profit will be $10.76B for 21.45 P/E if the $2.19 EPS becomes a reality. After $2.73 actual earnings per share reported by Apple Inc. for the previous quarter, Wall Street now forecasts -19.78% negative EPS growth.

Boston Scientific Corporation (NYSE:BSX) Institutional Positions Chart